Lymphocyte cytotoxicity of patients developing multiple primary melanomas

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• Patients with multiple primary melanomas often exhibit intact cellular immunity.
• Natural killer (NK) cell cytotoxicity is a key component of cellular immunity against tumors.

Purpose of the Study:

• To investigate the role of NK cell-mediated cytotoxicity in patients with multiple primary melanomas.
• To determine if NK cell activity correlates with the development of additional melanomas.
• To assess the antigenic relationship between different primary melanoma tumors in the same patient.

Main Methods:

• Assessed in vitro cytotoxicity of lymphocytes (unfractionated, T cell-enriched, NK cell-enriched) against melanoma and non-melanoma target cells using the 3H proline microcytotoxicity test.
• Established two melanoma cell lines from separate primary tumors of a single patient.
• Performed cytotoxicity assays using patient lymphocytes against these established cell lines.

Main Results:

• All 6 patients demonstrated NK cell activity against tumor targets.
• NK cell activity was present even in patients who developed additional primary melanomas.
• One of two melanoma cell lines from the same patient was resistant to lysis by patient's lymphocytes, indicating antigenic heterogeneity.

Conclusions:

• In vitro NK cell cytotoxicity does not appear to provide significant protection against the development of multiple primary melanomas.
• Antigenic heterogeneity between distinct primary tumors may explain the lack of protective immunity.
• Further research is needed to understand the mechanisms underlying multiple primary melanoma development.